By using a genetic technique developed at UT Southwestern Medical Center that forces cells to rid themselves of mitochondria, ...

"We're trying to move away a little bit from the notion that seven out of eight or six out of eight is better than five out ...

Less emphasis on full HLA matching means clinicians can find an appropriate donor for any patient, says Antonio Jimenez ...

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

A new way to grow stem cells may help them release more of the signaling proteins they use to repair tissue, potentially ...

Danie van der Lith EVERY year, on July 18, South Africans roll up their sleeves for Mandela Day. Offices empty out as teams head off to paint classrooms, pack food parcels, and spend their 67 minutes ...

Imagine losing a limb and growing it back like nothing ever happened. Sounds like science fiction? Not for many animals in ...

Findings demonstrating the early-stage success of genetically modified stem cell-derived islet (SC-islet) replacement therapies for the treatment of type 1 diabetes, leveraging a novel safety ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers ...

Detailed price information for Ascentage Pharma Group Intl ADR (AAPG-Q) from The Globe and Mail including charting and trades.

In the approach being tested in the trial, stem cells are collected from the vertebral column of deceased individuals who previously consented to organ donation. This clinical trial uses an innovative ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...